Stimulation of bile acid 6α-hydroxylation by rifampin

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Hepatology

• Publication date

  1996-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0168-8278(96)80268-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The major metabolites of ursodeoxycholic acid in human urine are conjugated with N‐acetylglucosamine

  1994cited by this paper
• Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.

  1992cited by this paper
• Effects of long-term rifampicin administration in primary biliary cirrhosis

  1992cited by this paper
• Urinary excretion of bile acid glucosides and glucuronides in extrahepatic cholestasis

  1991cited by this paper
• Unusual trihydroxy bile acids in the urine of patients treated with chenodeoxycholate, ursodeoxycholate or rifampicin and those with cirrhosis

  1990cited by this paper
• Rifampin relieves pruritus in children with cholestatic liver disease.

  1990cited by this paper
• Fecal Bile Acids

  1988cited by this paper
• Urinary Bile Acids

  1988cited by this paper
• Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial.

  1988cited by this paper
• Effective glucuronidation of 6α‐hydroxylated bile acids by human hepatic and renal microsomes

  1988cited by this paper
• Glucuronidation of 6 alpha-hydroxy bile acids by human liver microsomes.

  1987cited by this paper
• Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin.

  1987cited by this paper
• 6α-Glucuronidation of hyodeoxycholic acid by human liver, kidney and small bowel microsomes

  1987cited by this paper
• Pruritus in hepatic cholestasis. Pathogenesis and therapy.

  1985cited by this paper
• Hepatic and extrahepatic glucuronidation of bile acids in man. Characterization of bile acid uridine 5'-diphosphate-glucuronosyltransferase in hepatic, renal, and intestinal microsomes.

  1984cited by this paper
• The Liver: Biology and Pathobiology

  1983cited by this paper
• Intestinal absorption, excretion, and biotransformation of hyodeoxycholic acid in man.

  1983cited by this paper
• Assessment of urinary 6 beta-hydroxycortisol as an in vivo index of mixed-function oxygenase activity.

  1981cited by this paper
• Metabolism and pharmacokinetics of the antibiotic rifampin.

  1981cited by this paper
• Pruritus in cholestasis: no direct causative role for bile acid retention.

  1981cited by this paper
• Bile acid UDP‐glucoronyltransferase from human liver

  1980cited by this paper
• Bile acids and their sulphated and glucuronidated derivatives in bile, plasma, and urine of children with intrahepatic cholestasis: effects of phenobarbital treatment

  1980cited by this paper
• Analysis of bile acid glucuronides in urine. Identification of 3α,6α,12α-trihydroxy-5β-cholanoic acid

  1980cited by this paper
• Hydroxylation of cholic, chenodeoxycholic, and deoxycholic acids in patients with intrahepatic cholestasis.

  1980cited by this paper
• Bile acid profiles in urine of patients with liver diseases

  1979cited by this paper
• Metabolism of fetal and neonatal adrenal steroids.

  1979cited by this paper
• Clinical Pharmacokinetics of Rifampicin

  1978cited by this paper
• Glucuronides of unconjugated 6-hydroxylated bile acids in urine of a patient with malabsorption.

  1978cited by this paper
• The identification and quantification of three new 6alpha-hydroxylated corticosteroids in human neonatal urine.

  1978cited by this paper
• A direct radioimmunoassay for 6β-hydroxycortisol in human urine

  1978cited by this paper
• Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and topruritus.

  1977cited by this paper
• Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man.

  1977cited by this paper
• Pruritus induced by crude bile and purified bile acids. Experimental production of pruritus in human skin.

  1974cited by this paper
• Bile-salt glucuronides in urine.

  1974cited by this paper
• [Bile acids and bile acid sulfates in the skin of patients with cholestasis and pruritus].

  1974cited by this paper
• Pruritic Effect of Bile Salts

  1974cited by this paper
• Bile Acids on the Skin of Patients with Pruritic Hepatobiliary Disease

  1967cited by this paper
• PATHOGENESIS AND THERAPY

  1954cited by this paper

• FXR crosstalk with other nuclear receptors

  2025cites this paper
• Rifampicin prevents diet-induced obesity through Sirt6-dependent lipolysis, adipocyte browning and lipogenesis inhibition.

  2025cites this paper
• Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials

  2024cites this paper
• Clinicopathologic Features, Genetics, Treatment, and Long-Term Outcomes in Japanese Children and Young Adults with Benign Recurrent Intrahepatic Cholestasis: A Multicenter Study

  2023cites this paper
• Efficient stereoselective hydroxylation of deoxycholic acid by the robust whole-cell cytochrome P450 CYP107D1 biocatalyst

  2023cites this paper
• Indications and Contraindications for Pediatric Liver Transplant

  2021cites this paper
• Cholestasis-Associated Pruritus and Its Pruritogens

  2021cites this paper
• Mathematical recalibration of total bile acids: comparing the incomparable?

  2021cites this paper
• Was der (Viszeral-)Chirurg als neue Erkenntnisse über die Gallensäuren und deren Zusammenspiel mit dem Darmmikrobiom wissen sollte

  2020cites this paper
• New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin

  2020cites this paper
• Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids.

  2020cites this paper
• Alagille Syndrome: Diagnostic Challenges and Advances in Management

  2020cites this paper
• Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches

  2019cites this paper
• The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review

  2019cites this paper
• Rifampicin, Not Vitamin E, Suppresses Parenteral Nutrition Associated Liver Disease Development through Pregnane X Receptor Pathway in Piglets.

  2019cites this paper
• An update on the physiopathology and therapeutic management of cholestatic pruritus in children.

  2017cites this paper
• [Physiopathology and management of cholestatic pruritus in children].

  2017cites this paper
• Therapeutic potential of Omega-3 polyunsaturated fatty acids in the treatment of hepatobiliary diseases

  2016cites this paper
• Upregulation of UGT2B4 Expression by 3′-Phosphoadenosine-5′-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation

  2015cites this paper
• The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis.

  2014cites this paper
• Management of Cholestatic Pruritus in Paediatric Patients With Alagille Syndrome: The King's College Hospital Experience

  2013cites this paper
• The role of glucocorticoid metabolism in bile acid homeostasis

  2013cites this paper
• Canalicular ABC transporters and liver disease

  2012cites this paper
• Characterization of urinary bile acids in a pediatric BRIC-1 patient: effect of rifampicin treatment.

  2012cites this paper
• Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors.

  2012cites this paper
• Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease.

  2011cites this paper
• Current Management of Primary Sclerosing Cholangitis in Pediatric Patients

  2011cites this paper
• Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels.

  2010cites this paper
• Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potential

  2010cites this paper
• Liver disease associated with canalicular transport defects: current and future therapies.

  2010cites this paper
• Analysis of Bile Acids

  2010cites this paper
• Progressive familial intrahepatic cholestasis : Clinical, biochemical, genetic and histopathological aspects

  2009cites this paper
• Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor.

  2009cites this paper
• Novel Polymorphic Human UDP-glucuronosyltransferase 2A3: Cloning, Functional Characterization of Enzyme Variants, Comparative Tissue Expression, and Gene Induction

  2008cites this paper
• Clinical features and management of primary biliary cirrhosis.

  2008cites this paper
• Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis

  2008cites this paper
• Identification of Human Hepatic Cytochrome P450 Enzymes Involved in the Biotransformation of Cholic and Chenodeoxycholic Acid

  2008cites this paper
• The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences.

  2008cites this paper
• The Jaundiced Baby

  2007cites this paper
• New perspectives for the treatment of cholestasis: lessons from basic science applied clinically.

  2007cites this paper
• Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin.

  2006cites this paper
• Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides.

  2006cites this paper
• Induction of cytochrome P450‐dependent monooxygenase by extracts of the medicinal herb Salvia miltiorrhiza

  2006cites this paper
• Pregnane X Receptor Is a Target of Farnesoid X Receptor*

  2006cites this paper
• Troglitazone and liver injury: In search of answers

  2005cites this paper
• Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease?

  2005cites this paper
• A Pregnane X Receptor Agonist with Unique Species-Dependent Stereoselectivity and Its Implications in Drug Development

  2005cites this paper
• Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR.

  2005cites this paper
• Novel pathways of bile acid metabolism involving CYP3A4.

  2005cites this paper
• LINICAL – LIVER , PANCREAS , AND BILIARY TRACT omplementary Stimulation of Hepatobiliary Transport and etoxification Systems by Rifampicin and Ursodeoxycholic Acid n Humans

  2005cites this paper
• Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans.

  2005cites this paper
• Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.

  2005cites this paper
• Coordinate Regulation of Drug Metabolism by Xenobiotic Nuclear Receptors: UGTs Acting Together with CYPs and Glucuronide Transporters

  2004cites this paper
• Growth hormone modulation of the rat hepatic bile transporter system in endotoxin-induced cholestasis.

  2003cites this paper
• Bile salt transporters: molecular characterization, function, and regulation.

  2003cites this paper
• Cholesterol and Bile Acids Regulate Xenosensor Signaling in Drug-mediated Induction of Cytochromes P450*

  2002cites this paper
• Rifampicin and treatment of cholestatic pruritus

  2002cites this paper
• O Prurido da Colestase

  2002cites this paper
• Regulation of Hepatic Drug Metabolism: Role of the Nuclear Receptors PXR and CAR

  2002cites this paper
• Regulation of cyp3a gene transcription by the pregnane x receptor.

  2002cites this paper
• Nuclear xeno‐sensors as receptors for cholestatic bile acids: The second line of defense

  2002cites this paper
• An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids

  2001cites this paper
• Cloning and expression of a pig liver taurochenodeoxycholic acid 6alpha-hydroxylase (CYP4A21): a novel member of the CYP4A subfamily.

  2001cites this paper
• The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

  2001cites this paper
• Effect of silymarin on biliary bile salt secretion in the rat.

  2000cites this paper
• Hepatology

  1999cites this paper
• Use of rifampin for severe pruritus in children with chronic cholestasis.

  1999cites this paper
• 6α-Hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes

  1999cites this paper
• Intrahepatic Cholestatic Syndromes: Pathogenesis, Clinical Features and Management

  1999cites this paper
• Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of γ-glutamyl transpeptidase

  1998cites this paper
• SXR, a novel steroid and xenobiotic-sensing nuclear receptor.

  1998cites this paper